Integra LifeSciences Holdings (IART) Debt/Assets Ratio: History & Chart

Integra LifeSciences Holdings Corporation(IART)

Medical - Devices · Princeton, NJ

$12.92-0.37 (-2.75%)

Delayed quote: Oct 6, 2026, 10:20 AM EDT

About Integra LifeSciences Holdings Corporation

Integra LifeSciences Holdings Corporation is a medical technology company focused on the creation, production, and global distribution of advanced surgical implants and instruments. These products are utilized across various medical fields, including neurosurgery, limb reconstruction, and general surgical procedures. The company operates through two primary business segments: Codman Specialty Surgical and Tissue Technologies. The Codman Specialty Surgical division offers a comprehensive range of neurosurgical and neuro-critical care products. This includes specialized equipment for tissue ablation, dural repair solutions, cerebral spinal fluid management systems, intracranial monitoring tools, and cranial stabilization devices. Additionally, this segment provides surgical headlamps, various instrumentation, and supports these offerings with asset management software, technical assistance, and after-market services. Integra also supplies an extensive catalog of approximately 40,000 surgical instrument designs, along with a wide selection of surgical and lighting products. Its clientele spans hospitals, surgical centers, and extends to dental, podiatry, and veterinary practices. The Tissue Technologies segment specializes in innovative regenerative technology products for the treatment of both acute and chronic wounds. It further provides surgical tissue repair solutions for a multitude of applications, such as hernia repair, peripheral nerve protection and regeneration, and tendon reconstruction. This encompasses a broad array of offerings for skin and wound repair, plastic and reconstructive surgery products, bone grafting materials, and specialized nerve and tendon repair products. Integra LifeSciences distributes its diverse product portfolio internationally, reaching markets throughout the United States, Europe, Asia Pacific, and other global regions. Distribution is managed directly through its dedicated sales forces and various other channels, serving a wide array of healthcare entities including hospitals, integrated health networks, group purchasing organizations, individual clinicians, surgery centers, and other healthcare providers. Founded in 1989, Integra LifeSciences Holdings Corporation is headquartered in Princeton, New Jersey.

Princeton, NJ

4,427 employees

www.integralife.com

Healthcare / Medical - Devices

Sector: Healthcare
Industry: Medical - Devices
CEO: Stuart Essig

View full financials

IART Debt to Assets Ratio Metrics

DEBT TO ASSETS RATIO

56.87%

DEBT TO ASSETS RATIO AVG TTM

56.05%

DEBT TO ASSETS RATIO AVG 3Y

50.74%

DEBT TO ASSETS RATIO AVG 5Y

48.30%

DEBT TO ASSETS RATIO AVG 10Y

46.60%

DEBT TO ASSETS RATIO AVG 15Y

43.94%

DEBT TO ASSETS RATIO AVG 20Y

45.35%

CURRENT VS TTM AVG

+1.47%

CURRENT VS 3Y AVG

+12.09%

CURRENT VS 5Y AVG

+17.74%

CURRENT VS 10Y AVG

+22.03%

CURRENT VS 15Y AVG

+29.42%

CURRENT VS 20Y AVG

+25.42%

SECTOR MEDIAN · HEALTHCARE

0.10%

median of 584 covered companies

CURRENT VS SECTOR MEDIAN

+56771.80%

vs the sector median at left

NAME	MARKET CAP	DEBT TO ASSETS RATIO	TTM	3Y	5Y
Integra LifeSciences Holdings Corporation (IART)	$1.01B	56.87%	56.05%	50.74%	48.30%
Cullinan Therapeutics, Inc. (CGEM)vs ›	$1.00B	0.01%	N/A	N/A	N/A
Immatics N.V. (IMTX)vs ›	$1.01B	0.03%	N/A	N/A	N/A
Latigo Biotherapeutics Inc. (LTGO)vs ›	$997.34M	N/A	N/A	N/A	N/A
Janux Therapeutics, Inc. (JANX)vs ›	$997.11M	0.02%	N/A	N/A	N/A
Lumexa Imaging Holdings, Inc. Common Stock (LMRI)vs ›	$1.01B	0.54%	N/A	N/A	N/A
MeiraGTx Holdings plc (MGTX)vs ›	$983.05M	0.28%	N/A	N/A	N/A
Aktis Oncology, Inc. (AKTS)vs ›	$978.64M	0.02%	N/A	N/A	N/A
LB Pharmaceuticals Inc Common Stock (LBRX)vs ›	$967.55M	0.01%	N/A	N/A	N/A
Teladoc Health, Inc. (TDOC)vs ›	$1.04B	0.38%	N/A	N/A	N/A

NAME

MARKET CAP

DEBT TO ASSETS RATIO

TTM

Integra LifeSciences Holdings Corporation (IART)

$1.01B

56.87%

56.05%

50.74%

48.30%

Cullinan Therapeutics, Inc. (CGEM)vs ›

$1.00B

0.01%

N/A

Immatics N.V. (IMTX)vs ›

$1.01B

0.03%

N/A

Latigo Biotherapeutics Inc. (LTGO)vs ›

$997.34M

N/A

Janux Therapeutics, Inc. (JANX)vs ›

$997.11M

0.02%

N/A

Lumexa Imaging Holdings, Inc. Common Stock (LMRI)vs ›

$1.01B

0.54%

N/A

MeiraGTx Holdings plc (MGTX)vs ›

$983.05M

0.28%

N/A

Aktis Oncology, Inc. (AKTS)vs ›

$978.64M

0.02%

N/A

LB Pharmaceuticals Inc Common Stock (LBRX)vs ›

$967.55M

0.01%

N/A

Teladoc Health, Inc. (TDOC)vs ›

$1.04B

0.38%

N/A

Debt to Assets Ratio FAQ

What is the debt to assets ratio for Integra LifeSciences Holdings Corporation (IART)?

The debt to assets ratio for IART stock is 56.87%.

Is Integra LifeSciences Holdings Corporation's debt to assets ratio high or low?

The debt to assets ratio of 56.87% is 18% above its 5-year average of 48.30%, near the high end of its 5-year range (41.90%–57.00%).

What is the TTM average debt to assets ratio for Integra LifeSciences Holdings Corporation (IART)?

The TTM average debt to assets ratio for IART stock is 56.05%.

What is the 3Y average debt to assets ratio for Integra LifeSciences Holdings Corporation (IART)?

The 3Y average debt to assets ratio for IART stock is 50.74%.

What is the 5Y average debt to assets ratio for Integra LifeSciences Holdings Corporation (IART)?

The 5Y average debt to assets ratio for IART stock is 48.30%.

What is the 10Y average debt to assets ratio for Integra LifeSciences Holdings Corporation (IART)?

The 10Y average debt to assets ratio for IART stock is 46.60%.

What is the 15Y average debt to assets ratio for Integra LifeSciences Holdings Corporation (IART)?

The 15Y average debt to assets ratio for IART stock is 43.94%.

What is the 20Y average debt to assets ratio for Integra LifeSciences Holdings Corporation (IART)?

The 20Y average debt to assets ratio for IART stock is 45.35%.

DATE	DEBT TO ASSETS RATIO
2026-06-30	56.87%
2026-03-31	57.00%
2025-12-31	56.45%
2025-09-30	55.01%
2025-06-30	54.90%
2025-03-31	49.82%
2024-12-31	49.15%
2024-09-30	48.93%
2024-06-30	49.32%
2024-03-31	50.08%
2023-12-31	44.47%
2023-09-30	45.18%
2023-06-30	42.44%
2023-03-31	43.06%
2022-12-31	41.90%
2022-09-30	45.39%
2022-06-30	46.05%
2022-03-31	45.30%
2021-12-31	44.05%
2021-09-30	44.14%
2021-06-30	44.89%
2021-03-31	46.78%
2020-12-31	45.79%
2020-09-30	47.20%
2020-06-30	49.46%
2020-03-31	35.67%
2019-12-31	44.50%
2019-09-30	45.95%
2019-06-30	44.36%
2019-03-31	42.57%
2018-12-31	43.57%
2018-09-30	45.06%
2018-06-30	46.35%
2018-03-31	56.41%
2017-12-31	57.33%
2017-09-30	48.44%
2017-06-30	41.88%
2017-03-31	41.73%
2016-12-31	36.78%
2016-09-30	37.63%
2016-06-30	38.89%
2016-03-31	39.89%
2015-12-31	40.29%
2015-09-30	39.93%
2015-06-30	39.94%
2015-03-31	39.79%
2014-12-31	39.91%
2014-09-30	40.30%
2014-06-30	40.37%
2014-03-31	40.43%
2013-12-31	32.77%
2013-09-30	46.04%
2013-06-30	45.75%
2013-03-31	45.08%
2012-12-31	44.65%
2012-09-30	43.67%
2012-06-30	44.41%
2012-03-31	45.15%
2011-12-31	46.52%
2011-09-30	46.11%
2011-06-30	12.51%
2011-03-31	20.48%
2010-12-31	39.64%
2010-09-30	38.94%
2010-06-30	39.49%
2010-03-31	39.74%
2009-12-31	41.01%
2009-09-30	41.25%
2009-06-30	48.20%
2009-03-31	53.38%
2008-12-31	57.04%
2008-09-30	55.17%
2008-06-30	52.18%
2008-03-31	58.54%
2007-12-31	55.01%
2007-09-30	55.55%
2007-06-30	57.95%
2007-03-31	35.31%
2006-12-31	35.86%
2006-09-30	34.26%
2006-06-30	32.16%
2006-03-31	27.29%
2005-12-31	26.40%
2005-09-30	25.43%
2005-06-30	26.38%
2005-03-31	25.22%
2004-12-31	26.03%
2004-09-30	27.08%
2004-06-30	27.18%
2004-03-31	28.43%
2003-12-31	28.91%
2003-09-30	29.79%
2003-06-30	30.48%
2003-03-31	29.34%
2002-12-31	0.00%
2002-09-30	0.00%

DATE

DEBT TO ASSETS RATIO

2026-06-30

56.87%

2026-03-31

57.00%

2025-12-31

56.45%

2025-09-30

55.01%

2025-06-30

54.90%

2025-03-31

49.82%

2024-12-31

49.15%

2024-09-30

48.93%

2024-06-30

49.32%

2024-03-31

50.08%

2023-12-31

44.47%

2023-09-30

45.18%

2023-06-30

42.44%

2023-03-31

43.06%

2022-12-31

41.90%

2022-09-30

45.39%

2022-06-30

46.05%

2022-03-31

45.30%

2021-12-31

44.05%

2021-09-30

44.14%

2021-06-30

44.89%

2021-03-31

46.78%

2020-12-31

45.79%

2020-09-30

47.20%

2020-06-30

49.46%

2020-03-31

35.67%

2019-12-31

44.50%

2019-09-30

45.95%

2019-06-30

44.36%

2019-03-31

42.57%

2018-12-31

43.57%

2018-09-30

45.06%

2018-06-30

46.35%

2018-03-31

56.41%

2017-12-31

57.33%

2017-09-30

48.44%

2017-06-30

41.88%

2017-03-31

41.73%

2016-12-31

36.78%

2016-09-30

37.63%

2016-06-30

38.89%

2016-03-31

39.89%

2015-12-31

40.29%

2015-09-30

39.93%

2015-06-30

39.94%

2015-03-31

39.79%

2014-12-31

39.91%

2014-09-30

40.30%

2014-06-30

40.37%

2014-03-31

40.43%

2013-12-31

32.77%

2013-09-30

46.04%

2013-06-30

45.75%

2013-03-31

45.08%

2012-12-31

44.65%

2012-09-30

43.67%

2012-06-30

44.41%

2012-03-31

45.15%

2011-12-31

46.52%

2011-09-30

46.11%

2011-06-30

12.51%

2011-03-31

20.48%

2010-12-31

39.64%

2010-09-30

38.94%

2010-06-30

39.49%

2010-03-31

39.74%

2009-12-31

41.01%

2009-09-30

41.25%

2009-06-30

48.20%

2009-03-31

53.38%

2008-12-31

57.04%

2008-09-30

55.17%

2008-06-30

52.18%

2008-03-31

58.54%

2007-12-31

55.01%

2007-09-30

55.55%

2007-06-30

57.95%

2007-03-31

35.31%

2006-12-31

35.86%

2006-09-30

34.26%

2006-06-30

32.16%

2006-03-31

27.29%

2005-12-31

26.40%

2005-09-30

25.43%

2005-06-30

26.38%

2005-03-31

25.22%

2004-12-31

26.03%

2004-09-30

27.08%

2004-06-30

27.18%

2004-03-31

28.43%

2003-12-31

28.91%

2003-09-30

29.79%

2003-06-30

30.48%

2003-03-31

29.34%

2002-12-31

0.00%

2002-09-30

0.00%

Debt to Assets Ratio: 56.87%

IART Debt to Assets Ratio

IART Average Debt to Assets Ratio Chart

IART Current vs Average Debt to Assets Ratio Chart

IART Debt to Assets Ratio Metrics

IART Competitors' Debt to Assets Ratio

Leverage Ratios Comparison

Debt to Assets Ratio Formula & Definition

Debt to Assets Ratio FAQ

IART Debt to Assets Ratio History

Related Metrics